← All companies
Regencell Bioscience Holdings Ltd
RGC - CIK 0001829667
Market cap$9.31 B
Rank#993
SEC filings82
The table below shows Regencell Bioscience Holdings Ltd's balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | $6.42M | $59.41K |
| Short-term investments | $2.48M | $5.00M | $10.00M | $10.00M | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $4.90M | $8.11M | $11.62M | $16.44M | $66.85K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.